Determination of EGFR status in gliomas: Usefulness of immunohistochemistry and fluorescent in situ hybridization

Applied Immunohistochemistry and Molecular Morphology

Volumn 17, Issue 3, 2009, Pages 220-226

  Guillaudeau, Angélique ^a   Durand, Karine ^a   Pommepuy, Isabelle ^a   Robert, Sandrine ^a   Chaunavel, Alain ^a   Lacorre, Sylvain ^a   DeArmas, Rafaël ^a   Bourtoumieux, Sylvie ^a   El Demery, Mounira ^a   Moreau, Jean Jacques ^a   Labrousse, François ^a  

^a DUPUYTREN UNIVERSITY HOSPITAL   (France)

Author keywords

EGFR; Fluorescent in situ hybridization; Gliomas; Immunohistochemistry

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR;

ACCURACY; ADULT; AGED; ARTICLE; ASTROCYTOMA; CANCER STAGING; CHILD; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; GLIOBLASTOMA; GLIOMA; HISTOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; OLIGODENDROGLIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN EXPRESSION; ADOLESCENT; BRAIN TUMOR; GENETICS; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; FEMALE; GENE AMPLIFICATION; GLIOMA; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MIDDLE AGED; RECEPTOR, EPIDERMAL GROWTH FACTOR; YOUNG ADULT;

EID: 66549103474     PISSN: 15412016     EISSN: 15334058     Source Type: Journal    
DOI: 10.1097/PAI.0b013e31818db320     Document Type: Article

References (43)

1. Salomon DS, Brandt R, Ciardiello F, et al. Epidermal growth factor-related peptides and their receptors in human malignancies. Crit Rev Oncol Hematol. 1995;19:183-232.
2. Torp SH, Gulati S, Johannessen E, et al. Coexpression of c-erbB 1-4 receptor proteins in human glioblastomas. An immunohistochemical study. J Exp Clin Cancer Res. 2007;26:353-359. (Pubitemid 47584810)
3. Dancey JE, Freidlin B. Targeting epidermal growth factor receptor-are we missing the mark? Lancet. 2003;362:62-64.
4. Louis DN, Ohgaki H, Wiestler OD, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol. 2007;114:97-109.
5. Krex D, Klink B, Hartmann C, et al. Long-term survival with glioblastoma multiforme. Brain. 2007;130:2596-2606.
6. Lassman AB, Rossi MR, Raizer JJ, et al. Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01. Clin Cancer Res. 2005;11: 7841-7850.
7. Nakamura JL. The epidermal growth factor receptor in malignant gliomas: pathogenesis and therapeutic implications. Expert Opin Ther Targets. 2007;11:463-472. (Pubitemid 46487595)
8. Andersson U, Guo D, Malmer B, et al. Epidermal growth factor receptor family (EGFR, ErbB2-4) in gliomas and meningiomas. Acta Neuropathol. 2004;108:135-142. (Pubitemid 39136299)
9. Bredel M, Pollack IF, Hamilton RL, et al. Epidermal growth factor receptor expression and gene amplification in high-grade nonbrainstem gliomas of childhood. Clin Cancer Res. 1999;5:1786-1792. (Pubitemid 29334460)
10. McLendon RE, Turner K, Perkinson K, et al. Second messenger systems in human gliomas. Arch Pathol Lab Med. 2007;131: 1585-1590. (Pubitemid 47606727)
11. Potti A, Forseen SE, Koka VK, et al. Determination of HER-2/neu overexpression and clinical predictors of survival in a cohort of 347 patients with primary malignant brain tumors. Cancer Invest. 2004; 22:537-544. (Pubitemid 39506874)
12. Schlegel J, Stumm G, Brandle K, et al. Amplification and differential expression of members of the erbB-gene family in human glioblastoma. J Neurooncol. 1994;22:201-207.
13. Tabori U, Rienstein S, Dromi Y, et al. Epidermal growth factor receptor gene amplification and expression in disseminated pediatric low-grade gliomas. J Neurosurg. 2005;103:357-361. (Pubitemid 44954891)
14. Gil-Benso R, Lopez-Gines C, Benito R, et al. Concurrent EGFR amplification and TP-53 mutation in glioblastomas. Clin Neuropathol. 2007;26:224-231. (Pubitemid 47403417)
15. Okada Y, Ohno C, Ueki K, et al. Comparison of numerical change of epidermal growth factor receptor gene among pre and postradiation glioma, and gliosis, and its clinical use. Brain Tumor Pathol. 2007;24:15-18. (Pubitemid 46836352)
16. Schober R, Bilzer T, Waha A, et al. The epidermal growth factor receptor in glioblastoma: genomic amplification, protein expression, and patient survival data in a therapeutic trial. Clin Neuropathol. 1995;14:169-174.
17. Shinojima N, Tada K, Shiraishi S, et al. Prognostic value of epidermal growth factor receptor in patients with glioblastoma multiforme. Cancer Res. 2003;63:6962-6970. (Pubitemid 37322983)
18. Torp SH, Helseth E, Dalen A, et al. Epidermal growth factor receptor expression in human gliomas. Cancer Immunol Immunother. 1991;33:61-64.
19. Torp SH, Helseth E, Ryan L, et al. Amplification of the epidermal growth factor receptor gene in human gliomas. Anticancer Res. 1991;11:2095-2098.
20. Lal A, Glazer CA, Martinson HM, et al. Mutant epidermal growth factor receptor up-regulates molecular effectors of tumor invasion. Cancer Res. 2002;62:3335-3339. (Pubitemid 34651373)
21. Moroni M, Veronese S, Benvenuti S, et al. Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study. Lancet Oncol. 2005;6:279-286. (Pubitemid 40590264)
22. Cappuzzo F, Hirsch FR, Rossi E, et al. Epidermal growth factor receptor gene and protein and gefitinib sensitivity in non-small-cell lung cancer. J Natl Cancer Inst. 2005;97:643-655. (Pubitemid 40812628)
23. Ciardiello F, Tortora G. EGFR antagonists in cancer treatment. N Engl J Med. 2008;358:1160-1174.
24. Varella-Garcia M. Stratification of non-small cell lung cancer patients for therapy with epidermal growth factor receptor inhibitors: the EGFR fluorescence in situ hybridization assay. Diagn Pathol. 2006;1:19. (Pubitemid 44197190)
25. Korshunov A, Sycheva R, Golanov A. Molecular stratification of diagnostically challenging high-grade gliomas composed of small cells: the utility of fluorescence in situ hybridization. Clin Cancer Res. 2004;10:7820-7826. (Pubitemid 39587519)
26. Marks RA, Zhang S, Montironi R, et al. Epidermal growth factor receptor (EGFR) expression in prostatic adenocarcinoma after hormonal therapy: a fluorescence in situ hybridization and immunohistochemical analysis. Prostate. 2008;68:919-923. (Pubitemid 351794156)
27. Okuda K, Sasaki H, Kawano O, et al. Epidermal growth factor receptor gene mutation, amplification and protein expression in malignant pleural mesothelioma. J Cancer Res Clin Oncol. 2008;134: 1105-1111.
28. Hanawa M, Suzuki S, Dobashi Y, et al. EGFR protein overexpression and gene amplification in squamous cell carcinomas of the esophagus. Int J Cancer. 2006;118:1173-1180. (Pubitemid 43185604)
29. Hirsch FR, Varella-Garcia M, Bunn PA Jr, et al. Epidermal growth factor receptor in non-small-cell lung carcinomas: correlation between gene copy number and protein expression and impact on prognosis. J Clin Oncol. 2003;21:3798-3807. (Pubitemid 46606235)
30. Ionescu DN, Sasatomi E, Cieply K, et al. Protein expression and gene amplification of epidermal growth factor receptor in thymomas. Cancer. 2005;103:630-636.
31. Layfield LJ, Willmore C, Tripp S, et al. Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors. Appl Immunohistochem Mol Morphol. 2006;14:91-96.
32. Miller VA, Kris MG, Shah N, et al. Bronchioloalveolar pathologic subtype and smoking history predict sensitivity to gefitinib in advanced non-small-cell lung cancer. J Clin Oncol. 2004;22: 1103-1109. (Pubitemid 41095044)
33. Wacker B, Nagrani T, Weinberg J, et al. Correlation between development of rash and efficacy in patients treated with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib in two large phase III studies. Clin Cancer Res. 2007;13: 3913-3921. (Pubitemid 47037599)
34. Ekstrand AJ, James CD, Cavenee WK, et al. Genes for epidermal growth factor receptor, transforming growth factor alpha, and epidermal growth factor and their expression in human gliomas in vivo. Cancer Res. 1991;51:2164-2172.
35. Marquez A, Wu R, Zhao J, et al. Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy. Diagn Mol Pathol. 2004;13:1-8. (Pubitemid 38263876)
36. Huang H, Colella S, Kurrer M, et al. Gene expression profiling of low-grade diffuse astrocytomas by cDNA arrays. Cancer Res. 2000; 60:6868-6874. (Pubitemid 32059155)
37. van den Bent MJ, Kros JM. Predictive and prognostic markers in neuro-oncology. J Neuropathol Exp Neurol. 2007;66:1074-1081.
38. Frederick L, Wang XY, Eley G, et al. Diversity and frequency of epidermal growth factor receptor mutations in human glioblastomas. Cancer Res. 2000;60:1383-1387. (Pubitemid 30152011)
39. Lee JC, Vivanco I, Beroukhim R, et al. Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain. PLoS Med. 2006;3:e485. (Pubitemid 46028511)
40. Aldape KD, Ballman K, Furth A, et al. Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance. J Neuropathol Exp Neurol. 2004;63:700-707. (Pubitemid 38891086)
41. Feldkamp MM, Lala P, Lau N, et al. Expression of activated epidermal growth factor receptors, Ras-guanosine triphosphate, and mitogen-activated protein kinase in human glioblastoma multiforme specimens. Neurosurgery. 1999;45:1442-1453.
42. Huang PH, Mukasa A, Bonavia R, et al. Quantitative analysis of EGFRvIII cellular signaling networks reveals a combinatorial therapeutic strategy for glioblastoma. Proc Natl Acad Sci USA. 2007;104:12867-12872. (Pubitemid 47255246)
43. Mrhalova M, Plzak J, Betka J, et al. Epidermal growth factor receptor-its expression and copy numbers of EGFR gene in patients with head and neck squamous cell carcinomas. Neoplasma. 2005; 52:338-343. (Pubitemid 41076203)